Skip to main content

ARROWSTREET CAPITAL, LIMITED PARTNERSHIP

Position in CRL — Charles River Laboratories International, Inc.

CIK 1164508 BOSTON, MA

Position in CRL

as of Mar 31, 2026 · filed May 14, 2026
Position Value
$127,137,675
-$39,675,480 QoQ
Shares Held
737,030
-11.9% QoQ
Ownership
1.53%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2020
8 quarters on record
Voting authority Sole 97.93576923598768.ToString("F0")% Shared 0.ToString("F0")% None 2.0642307640123194.ToString("F0")%

Common Shares in CRL Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Mar 31, 2026

ARROWSTREET CAPITAL, LIMITED PARTNERSHIP holds $2,675,072,774 across 18 Diagnostics & Research names. CRL ranks #9 (4.8% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in CRL

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $127,137,675 737,030
2025-12-31 $166,813,155 836,240
2025-09-30 $120,386,113 769,437
2025-06-30 $87,792,343 578,609
2025-03-31 $53,221,162 353,582
2021-12-31 $17,671,358 46,901
2021-09-30 $19,808,160 48,000
2020-06-30 $488,180 2,800